Risk of Treatment-Related Toxicities from EGFR Tyrosine Kinase Inhibitors: A Meta-analysis of Clinical Trials of Gefitinib, Erlotinib, and Afatinib in Advanced EGFR-Mutated Non–Small Cell Lung Cancer

Pei Ni Ding, Sarah J. Lord, Val Gebski, Matthew Links, Victoria Bray, Richard J. Gralla, James Chih Hsin Yang, Chee Khoon Lee

Research output: Contribution to journalArticlepeer-review

63 Scopus citations

Fingerprint Dive into the research topics of 'Risk of Treatment-Related Toxicities from EGFR Tyrosine Kinase Inhibitors: A Meta-analysis of Clinical Trials of Gefitinib, Erlotinib, and Afatinib in Advanced EGFR-Mutated Non–Small Cell Lung Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences